The Neuro Panel by TRUPCR® is a powerful multiplex PCR assay designed to detect and differentiate 11 neurotropic viruses from cerebrospinal or respiratory specimens. Targets include Enterovirus, Epstein-Barr virus (EBV), Herpes simplex virus types 1 & 2, Cytomegalovirus (CMV), Varicella-Zoster virus (VZV), Adenovirus, Parechovirus, Parvovirus B19, and Human Herpesvirus 6 & 7. Built for clinical use in molecular diagnostics, the Neuro Panel incorporates “hot-start” technology to ensure high sensitivity and specificity, along with an endogenous internal control to validate sample integrity and rule out PCR inhibition. The kit uses multiplex reactions across four tubes, each optimized with three-color fluorescence detection, providing rapid and accurate results in a single workflow. Ideal for use in diagnosing viral meningoencephalitis, encephalopathy, and other CNS-related infections, the TRUPCR® Neuro Panel delivers unmatched diagnostic coverage and lab efficiency.
The Neuro Panel is a real-time PCR-based assay developed to detect 11 viral pathogens with neuroinvasive potential. The panel is distributed across four tubes, each containing multiplex reactions targeting distinct viruses with specific fluorescent channels:
This configuration supports simultaneous detection and differentiation from a single extracted sample. With its broad pathogen coverage and built-in internal control, the Neuro Panel streamlines diagnostics in complex neurological cases such as viral meningitis, encephalitis, and immunocompromised CNS infections.
Each virus included in the Neuro Panel plays a distinct role in neurological pathology:
A leading cause of viral meningitis and encephalitis in children, these RNA viruses can cause severe CNS complications and are classified as re-emerging threats.
Associated with infectious mononucleosis and post-transplant complications, EBV may trigger neurological issues in immunosuppressed patients.
Common agents in viral encephalitis, keratitis, and meningitis. HSV-1 typically affects the CNS, while HSV-2 is linked to neonatal infections and meningitis.
While mostly known for respiratory and GI infections, adenoviruses can cause febrile seizures and encephalitis, particularly in children and immunocompromised hosts.
This herpesvirus causes life-threatening CNS infections in neonates and immunosuppressed individuals. CMV reactivation is a major concern in transplant medicine.
These viruses are often implicated in febrile seizures and encephalitis in pediatric patients. Co-infections with HHV-6 and HHV-7 can complicate clinical diagnosis.
VZV reactivation may cause shingles-associated meningitis or encephalitis, especially in older adults or immunocompromised patients.
Typically asymptomatic, but in neonates, parechovirus can lead to severe meningoencephalitis and sepsis-like illness.
Though better known for causing fifth disease, it can also result in CNS manifestations like encephalitis and neuropathies, particularly in immunocompromised patients.
This comprehensive range ensures that even rare or atypical viral causes of neurological illness are not missed in diagnostic evaluations.
The TRUPCR® Neuro Panel Kit is an in vitro nucleic acid amplification assay validated for qualitative detection and differentiation of 11 neurotropic viruses using real-time PCR. Each component of the assay is optimized for sensitivity and specificity, based on CDC-recommended molecular design principles.
The test is compatible with a wide range of PCR platforms, making it adaptable to most clinical diagnostic environments.
The Neuro Panel operates through the following steps:
This setup enables accurate, reproducible results within a short turnaround time—critical for diagnosing acute neurological infections.
The Neuro Panel is ideal for use in:
By detecting both common and emerging neurotropic viruses, the TRUPCR® Neuro Panel empowers laboratories to deliver actionable diagnostic insights that support timely treatment, reduce hospital stays, and improve clinical outcomes.
Product Catalogus
For any missing information or if you require additional details, please do not hesitate to contact us.
Subscribe to our newsletter.